Promising breast cancer drug enters final phase of trials

Ellis utilizes genetic analysis to guide cancer therapy.A new breast cancer drug that has shown promise fighting a particularly tough type of tumor may become a viable option for cancer patients. Matthew Ellis, a WUSTL physician at the Siteman Cancer Center, has studied the medication, Lapatinib, since it first showed promise against breast cancer tumors. He is now conducting the final phase of trials for the drug. KSDK reporter Kay Quinn provides more details in the following St. Louis Post-Dispatch article.

Terrorism and Homeland Security Experts

Washington University has a number of internationally recognized experts and researchers on terrorism and homeland security who can address issues including intelligence, critical infrastructure, cybersecurity, target identification, and many other areas of concern related to the latest news on threats to the U.S. Faculty associated with the University’s Center for Security Technologies may be of […]

Sweat does more than just cool bodies

Everyone sweats, but it’s unlikely many people ever consider the social and economic impact of our bodies’ built-in air conditioning system. With summer’s hottest days likely still to come, Michael Heffernan, assistant professor of dermatology at the School of Medicine, helps St. Louis Post-Dispatch writer Jeff Daniels take a closer look at this hot topic.

Athletics help children with cerebral palsy become independent, active adults

Jan Brunstrom demonstrates martial arts moves with cerebral palsy patient Emma Price.A comprehensive care plan involving sports, physical fitness and strength training is key to helping children with cerebral palsy grow into active adults, according to WUSTL pediatric neurologist Jan Brunstrom. Not only are athletic activities fun for children, but they can also reduce the need for traditional therapy.
View More Stories